BDRX Stock Analysis: Buy, Sell, or Hold?
BDRX - Biodexa Pharmaceuticals plc American Depositary Shs
$1.27
0.01 (0.79%)
▲
5d:
-16.45%
30d:
-24.4%
90d:
-60.8%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Jun 26, 2026
0d
Get Alerted When BDRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: BDRX is down 16.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: BDRX is down 16.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: BDRX is currently trading at $1.27, which is considered oversold relative to its 30-day fair value range of $1.37 to $1.97.
Technical Outlook: Technically, BDRX is in a downtrend. Immediate support is located at $1.17, while resistance sits at $1.65.
Market Sentiment: BDRX scores 35/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $10.30 (+711.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BDRX is in a downtrend. Immediate support is located at $1.17, while resistance sits at $1.65.
Market Sentiment: BDRX scores 35/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $10.30 (+711.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.37 -
$1.97
Company Quality Score
44/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (35/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 711.2% below Wall St target ($10.30)
- WARNING: Composite score 44/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.37 -
$1.97
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.17
Resistance Level
$1.65
Current Trend
Downtrend
Technical data as of
Aug 21, 2026
Fundamental Context
Wall Street Target
$10.30
(+711.2%)
Revenue Growth (YoY)
-64.1%
Share & Embed Analysis
Last updated: August 23, 2026 10:29 AM ET
Data refreshes hourly during market hours. Next update: 11:29 AM
Data refreshes hourly during market hours. Next update: 11:29 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BDRX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 33 SELL |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1173 | 43 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$840 | 34 SELL |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$281 | 55 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$29 | 49 HOLD |
